Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD38-SADA |
Trade Name | |
Synonyms | Anti-CD38 scFv/Anti-DOTA scFv Fusion Protein CD38-SADA |
Drug Descriptions |
CD38-SADA is a fusion protein comprising a single chain variable fragment targeting CD38, a single chain variable fragment targeting the chelating agent DOTA, and a self-assembling and disassembling (SADA) domain, which potentially allows selective delivery of a radioactive payload to CD38-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | CD38 Antibody 21 |
CAS Registry Number | NA |
NCIT ID | C201289 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD38-SADA | CD38-SADA | 0 | 0 |
CD38-SADA + Lutetium Lu 177-DOTA | CD38-SADA Lutetium Lu 177-DOTA | 0 | 1 |